Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avinger Inc (NQ: AVGR )

0.8290 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avinger Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Avinger Inc. (NASDAQ: AVGR) Near Top of Volume Charts in Monday Trading
Via Investor Brand Network
US Stocks Mostly Higher; Dow Gains Over 50 Points
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.17% to 34,678.78 while the NASDAQ rose 0.09%... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023
Via ACCESSWIRE
Avinger Presents An Attractive Entry Point For Investors; Analyst Discusses Bull Case
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 57 companies reached new 52-week lows. 
Via Benzinga
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Avinger to Announce Second Quarter 2023 Results on July 27
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at LINC 2023
Via ACCESSWIRE
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
Via ACCESSWIRE
Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System
Via ACCESSWIRE
Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device
Via ACCESSWIRE
Avinger Reports First Quarter 2023 Results
Via ACCESSWIRE
Avinger to Announce First Quarter 2023 Results on May 10
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium
Via ACCESSWIRE
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
The biggest pre-market stock movers are ready to go as we dive into the latest news traders need to know about on Thursday! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
Avinger Reports Fourth Quarter 2022 Results
Via ACCESSWIRE
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
Avinger to Announce Fourth Quarter 2022 Results on March 15
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.